RESEARCH LIBRARY

Muscle Nerve, 58: 646-654

The Amyotrophic Lateral Sclerosis (ALS)‐Specific Quality of Life instrument and its revised version (ALSSQOL and ALSSQOL‐R) have strong psychometric properties, and have demonstrated research and clinical utility. This study aimed to develop a short form (ALSSQOL‐SF) suitable for limited clinic time and patient stamina.

Measurement: Interdisciplinary Research and Perspectives, 16:1, 59-70

This article critically reviews how diagnostic models have been conceptualized and how they compare to other approaches used in educational measurement. In particular, certain assumptions that have been taken for granted and used as defining characteristics of diagnostic models are reviewed and it is questioned whether these assumptions are the reason why these models have not had the success in operational analyses and large-scale applications, contrary to what many have hoped.

Qual Life Res 27, 1711–1720 (2018)

The US Food and Drug Administration (FDA), as part of its regulatory mission, is charged with determining whether a clinical outcome assessment (COA) is “fit for purpose” when used in clinical trials to support drug approval and product labeling. This paper provides a review (and some commentary) on the current state of affairs in COA development/evaluation/use with a focus on one aspect: How do you know you are measuring the right thing? In the psychometric literature, this concept is referred to broadly as validity and has itself evolved over many years of research and application.